Promising Pilot Study Finds Senolytics Safe in Older Adults with Cognitive Challenges
Researchers from Harvard Medical School, Mayo Clinic, Cedars-Sinai, Beth Israel Deaconess, and the Marcus Institute for Aging Research report encouraging news: the senolytic treatment combining dasatinib and quercetin (together known as D+Q) is safe and well-tolerated by older adults experiencing early memory and mobility issues. The Role of Senolytics